253 related articles for article (PubMed ID: 32771553)
1. Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study.
Li H; Ji J; Du Y; Huang Y; Gu H; Chen M; Wu R; Han B
Exp Hematol; 2020 Sep; 89():87-95. PubMed ID: 32771553
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus is effective for primary refractory/relapsed warm autoimmune haemolytic anaemia/Evans syndrome: a retrospective single-center study.
Zhang Z; Hu Q; Yang C; Chen M; Han B
Ann Med; 2023; 55(2):2282180. PubMed ID: 37967535
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus as an Effective Agent in the Treatment of Immune Thrombocytopenia (ITP) and Evans Syndrome (ES): A Single Institution's Experience.
Jasinski S; Weinblatt ME; Glasser CL
J Pediatr Hematol Oncol; 2017 Aug; 39(6):420-424. PubMed ID: 28267088
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology/oncology.
Miano M; Ramenghi U; Russo G; Rubert L; Barone A; Tucci F; Farruggia P; Petrone A; Mondino A; Lo Valvo L; Crescenzio N; Bellia F; Olivieri I; Palmisani E; Caviglia I; Dufour C; Fioredda F
Br J Haematol; 2016 Nov; 175(3):490-495. PubMed ID: 27447678
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus is effective in relapsed/refractory autoimmune cytopenias: results of a single-center retrospective study.
Du Y; Yang C; Chen M; Ruan J; Huang Y; Chen F; Han B
Hematology; 2020 Dec; 25(1):478-483. PubMed ID: 33297889
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
8. Neurological Involvement in Childhood Evans Syndrome.
Pincez T; Neven B; Le Pointe HD; Varlet P; Fernandes H; Gareton A; Leverger G; Leblanc T; Chambost H; Michel G; Pasquet M; Millot F; Hermine O; Mathian A; Hully M; Zephir H; Hamidou M; Durand JM; Perel Y; Landman-Parker J; Rieux-Laucat F; Aladjidi N
J Clin Immunol; 2019 Feb; 39(2):171-181. PubMed ID: 30671780
[TBL] [Abstract][Full Text] [Related]
9. Maintenence rituximab following induction in autoimmune cytopenias.
Rai MP; Lee EJ; Bussel JB
Br J Haematol; 2023 Jul; 202(1):153-158. PubMed ID: 37086173
[TBL] [Abstract][Full Text] [Related]
10. Primary Immunodeficiency in Children With Autoimmune Cytopenias: Retrospective 154-Patient Cohort.
Westermann-Clark E; Meehan CA; Meyer AK; Dasso JF; Amre D; Ellison M; Patel B; Betensky M; Hauk CI; Mayer J; Metts J; Leiding JW; Sriaroon P; Kumar A; Ayala I; Walter JE
Front Immunol; 2021; 12():649182. PubMed ID: 33968040
[TBL] [Abstract][Full Text] [Related]
11. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.
Olfat M; Silverman ED; Levy DM
Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672
[TBL] [Abstract][Full Text] [Related]
12. [Evans' syndrome: a retrospective study from the ship (French Society of Pediatric Hematology and Immunology) (36 cases)].
Blouin P; Auvrignon A; Pagnier A; Thuret I; Antoni G; Bader-Meunier B; Le Deist F; Chastagner P; Aladjidi N; Pellier I; Bertrand Y; Behar C; Landmann-Parker J; Leverger G; Perel Y
Arch Pediatr; 2005 Nov; 12(11):1600-7. PubMed ID: 16185853
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune Cytopenias Are Highly Associated with Inborn Errors of Immunity and They May Be the Initial Presentations in Cases without Severe Infections.
Taskin RB; Topyıldız E; Edeer Karaca N; Aksu G; Yılmaz Karapınar D; Kutukculer N
Int Arch Allergy Immunol; 2024; 185(4):392-401. PubMed ID: 38154455
[TBL] [Abstract][Full Text] [Related]
14. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and steroid-sparing effect of tacrolimus in patients with autoimmune cytopenia.
Zhang R; Chen M; Yang C; Han B
Ann Hematol; 2022 Nov; 101(11):2421-2431. PubMed ID: 36066607
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Hbibi M; El Alaoui El Hanafi M; Kasmi Z; Ouair H; Benmiloud S; Ailal F; Hida M; Bousfiha AA
Tunis Med; 2024 Jan; 102(1):1-6. PubMed ID: 38545722
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus is effective and safe in childhood relapsed-refractory autoimmune cytopenias: A multicentre study.
Acar SO; Tahta N; Al IO; Erdem M; Gözmen S; Karapınar TH; Kılınç B; Celkan T; Kirkiz S; Koçak Ü; Ören H; Yıldırım AT; Arslantaş E; Ayhan AC; Oymak Y
Scand J Immunol; 2024 May; ():e13376. PubMed ID: 38741164
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of children with chronic immune thrombocytopenic purpura and Evans syndrome treated with rituximab.
Gokcebay DG; Tavil B; Fettah A; Yarali N; Azik FM; Tunc B
Clin Appl Thromb Hemost; 2013; 19(6):663-7. PubMed ID: 22815318
[TBL] [Abstract][Full Text] [Related]
20. Addition of rituximab to standard therapy improves response rate and progression-free survival in relapsed or refractory thrombotic thrombocytopenic purpura and autoimmune haemolytic anaemia.
Heidel F; Lipka DB; von Auer C; Huber C; Scharrer I; Hess G
Thromb Haemost; 2007 Feb; 97(2):228-33. PubMed ID: 17264951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
